Vitamin c may cut anemia drug needs in dialysis patients
NCT ID NCT07076108
First seen Jan 06, 2026 · Last updated Apr 28, 2026 · Updated 18 times
Summary
This study looked at whether taking vitamin C by mouth can safely lower the dose of erythropoietin (a drug for anemia) needed by people with end-stage kidney disease on regular dialysis. Sixty adults on stable dialysis with low iron levels and moderate anemia took part. Researchers measured hemoglobin, iron levels, and erythropoietin dose changes over three months to see if vitamin C helped reduce the medication needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, 11591, Egypt
Conditions
Explore the condition pages connected to this study.